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• Significant jaundice based on bilirubin level for age and weight of newborn based on 
internationally accepted criteria [39] [40] 




• Initially well and then onset of spasms that maybe provoked or spontaneous 
• Trismus and difficulty feeding 
Neonatal 
Meningitis 
• Cerebrospinal fluid (CSF) culture positive for a causative organisms 
Or positive antigen test [42] 
• White cell count in cerebrospinal fluid of more than 50 cells per microlitre [42] 
o Positive blood culture and/or gram stain 
o Glucose blood/CSF ratio < 0.1 
o  
Neonatal Sepsis 
• Positive blood culture 




• Onset within 2 days of birth of severe or moderate neonatal encephalopathy in infants born at 34 
or more weeks of gestation  
• Acute perinatal event, and/or a 10 minute APGAR less than 5 or assisted ventilation for more 
than 10 minutes. 
• Ideally also the following: 
o Evidence of metabolic acidosis  (pH <7 or less or base deficit < 12 mmol per liter [43] 
o Other  identifiable aetiologies such as trauma, coagulation disorders, infectious 
conditions, or genetic disorders were excluded [43]. 
 
Preterm birth 
Documentation of gestation age below 37 completed weeks by:- 
• Where last menstrual period is known and expected date of delivery can calculated 
• Acceptable gestation age estimation criteria with  
o Ultrasound, ideally first trimester 
o Dubowitz score [44]  
o Other clinical scores with  validation published eg Eregie [45]  
HIV 
• Polymerase Chain Reactions (PCR) test that shows infection with the HIV virus,  
Toxoplasmosis 
• Serological diagnosis of infection in the mother through seroconversion, presence of IgA and 
IgM, low avidity IgG, or PCR in amniotic fluid [46, 47] 
• Immunological diagnosis in the newborn with suggestive clinical history [46, 47] 
• Histological diagnosis of the central nervous system tissues where post-mortem is done 
Rubella 
• Clinical diagnosis based on the classical triad of congenital heart disease, deafness and 
congenital cataracts, and history of maternal infection 
• Ideally also supportive laboratory evidence such as 
o  increased antibody  titres 
o Persistence of rubella-specific IgG in the infant after 6 to 12 months 
o Virus isolation from any site such as fetal blood or chorionic villus biopsy 
Cytomegalovirus • Documentation of maternal infections by either IgG avidity testing or documented sero-
conversion  
 • Detection of virus in the newborn from urine, saliva or blood  
Herpes 
• Isolation of Herpes simplex virus (HSV) from skin lesions, CSF, urine, throat, nasopharynx or 
conjunctivae 
   
• Detection of HSV DNA in CSF by PCR  
Syphilis 
 
• High neonatal antibody titres: ≥ 4 times above the maternal levels 
• Positive rapid plasma regain or venereal disease research laboratory [VDRL]) will also be 
considered 
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